IRVING, Texas, Oct. 23, 2017 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report third quarter 2017 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, November 3, 2017. Supplemental financial information, including the press release and investor presentation, will be released at approximately 5:00 am CT / 6:00 am ET and will also be available on the Company’s Investor Relations site at http://investor.hms.com.
| WHO: | William Lucia, Chairman & CEO | ||||
| Jeffrey Sherman, CFO | |||||
| WHEN: | Friday, November 3, 2017 | ||||
| 7:30 am CT / 8:30 am ET | |||||
| HOW: | Individuals may access the webcast at http://investor.hms.com/events.cfm or | ||||
| listen to the call at (877) 303-7208. International participants may listen to the call at (224) 357-2389 | |||||
| REPLAY: | The webcast will be archived on the Company’s website http://investor.hms.com/events.cfm | ||||
About HMS
HMS Holdings Corp., through its subsidiaries, provides coordination of benefits, payment integrity, and health management and member engagement solutions for payers. HMS serves state Medicaid programs; commercial health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; child support agencies; and other healthcare payers and sponsors. As a result of our services, customers recover billions of dollars annually and save billions more through the prevention of improper payments.
Investor Contact:
Dennis Oakes
SVP, Investor Relations
[email protected]
212-857-5786


Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 



